TABLE 1.
Description of the CLL/AML cohort by leukemia subtype: Puerto Rico, 2011–2015
| Characteristics | CLL (N = 518) | AML (N = 408) | ||
|---|---|---|---|---|
| Count | % | Count | % | |
| Sex | ||||
| Male | 306 | 59.1 | 208 | 51.0 |
| Female | 212 | 40.9 | 200 | 49.0 |
| Age group (years) | ||||
| <50 | 30 | 5.8 | 89 | 21.8 |
| 50–64 | 135 | 26.1 | 92 | 22.6 |
| 65–79 | 257 | 49.6 | 169 | 41.4 |
| 80+ | 96 | 18.5 | 58 | 14.2 |
| Previous cancer history | ||||
| No | 449 | 86.7 | 317 | 77.7 |
| Yes | 69 | 13.3 | 91 | 22.3 |
| Charlson comorbidity index | ||||
| 0 | 233 | 45.0 | 190 | 46.6 |
| 1 | 83 | 16.0 | 53 | 13.0 |
| ≥2 | 91 | 17.6 | 67 | 16.4 |
| Unknown | 111 | 21.4 | 98 | 24.0 |
| Insurance at diagnosis | ||||
| Private | 119 | 23.0 | 93 | 22.8 |
| Medicaid | 77 | 14.9 | 96 | 23.5 |
| Medicare/Medicaid | 117 | 22.6 | 99 | 24.3 |
| Medicare | 152 | 29.3 | 84 | 20.6 |
| Unknown/Other | 53 | 10.2 | 36 | 8.8 |